{"gene":"SLC32A1","run_date":"2026-06-10T07:46:33","timeline":{"discoveries":[{"year":1998,"finding":"VGAT (SLC32A1) protein specifically associates with synaptic vesicles in GABAergic and glycinergic nerve endings, as demonstrated by post-embedding immunogold quantification in rat CNS. It is the first vesicular amino acid transporter molecularly identified and defines a novel gene family distinct from other vesicular neurotransmitter transporters.","method":"Immunogold electron microscopy with epitope-specific antibodies (N- and C-terminal); triple immunolabeling for VGAT, GABA, and glycine","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct subcellular localization by quantitative immunogold EM, replicated across multiple brain regions and cell types, founding characterization paper","pmids":["9822734"],"is_preprint":false},{"year":2007,"finding":"VIAAT (SLC32A1) mediates vesicular loading of both glycine and GABA; the vesicular inhibitory phenotype (glycinergic vs GABAergic) is determined by competition between glycine and GABA for uptake by VIAAT, modulated by cytosolic amino acid concentrations established by plasmalemmal transporters. GlyT2 is more effective than GlyT1 in supporting glycinergic vesicular release because GlyT2 cannot operate in reverse mode, maintaining higher cytosolic glycine for VIAAT loading.","method":"Reconstitution in neuroendocrine cells expressing VIAAT with GlyT1, GlyT2, or GABAergic transporters; quantal release measured by double-sniffer patch-clamp technique; point mutation of UNC-47 (C. elegans VIAAT ortholog)","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Moderate — functional reconstitution in heterologous cells with direct quantal measurements, mutagenesis of ortholog, single lab but multiple orthogonal methods","pmids":["17554001"],"is_preprint":false},{"year":2012,"finding":"Reduced VGAT expression in heterozygous VGAT knockout mice selectively impairs glycinergic (not GABAergic) miniature inhibitory postsynaptic currents in spinal cord dorsal horn neurons, reducing both frequency and amplitude of glycinergic mIPSCs and shrinking the readily releasable pool of glycine-containing vesicles, leading to enhanced inflammatory pain.","method":"Heterozygous VGAT knockout mouse model; patch-clamp recording of mIPSCs in dorsal horn neurons; Western blot; behavioral assays; HPLC for amino acid content","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined electrophysiological and behavioral phenotype, multiple orthogonal methods in single lab","pmids":["22275517"],"is_preprint":false},{"year":2010,"finding":"VIAAT (SLC32A1) function in the CNS, not in the palate tissue itself, is required for normal palatogenesis. CNS-specific inactivation of Viaat is sufficient to cause cleft palate, and GABA-A receptor agonist muscimol rescues cleft palate in Viaat mutant embryos, indicating that vesicular inhibitory transmission acts through central GABAergic circuits to support palate development.","method":"Oral explant cultures; pharmacological rescue with muscimol; CNS-specific conditional Gad1 knockout; Viaat germline knockout mouse","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — three independent experimental approaches (explant culture, pharmacological rescue, conditional CNS-specific knockout), establishing pathway position","pmids":["20333300"],"is_preprint":false},{"year":2014,"finding":"VGAT knockout mouse cultured neurons and spinal cord show virtually no GABAergic or glycinergic inhibitory postsynaptic currents, establishing that VGAT is essential for vesicular loading and release of both GABA and glycine. Genetic epistasis with GAD67 and GAD65/67 double knockouts shows that both GABAergic (via both GAD isoforms) and glycinergic transmission contribute to palate and abdominal wall development, with VGAT loss producing the most severe phenotype.","method":"VGAT knockout, GAD67 knockout, and GAD65/GAD67 double knockout mice; electrophysiology (IPSC recording); anatomical phenotyping (cleft palate, omphalocele severity)","journal":"Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis across multiple knockout models with electrophysiological and anatomical readouts, establishing necessity of VGAT for inhibitory vesicular release","pmids":["25545713"],"is_preprint":false},{"year":2015,"finding":"In rat primary cortical neurons, VGLUT1 and VGAT (SLC32A1) are co-sorted into the same synaptic vesicles in a subset of axon terminals, enabling co-release of glutamate and GABA from the same terminal. These mixed synapses are regulated in an activity-dependent manner: reducing network excitation decreases VGLUT1/VGAT co-expressing terminals, while blocking inhibition increases them.","method":"Immunofluorescence confocal microscopy; electrophysiology with consecutive application of selective glutamate and GABA-A receptor blockers; pharmacological manipulation of network activity","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct electrophysiological demonstration of co-release plus imaging of co-localization; single lab, two orthogonal methods","pmids":["25749864"],"is_preprint":false},{"year":2018,"finding":"Conditional deletion of Vgat from ErbB4+ interneurons reduces inhibitory axo-somatic and axo-axonic synapses from PV+/ErbB4+ interneurons onto excitatory neurons and alters inhibitory neurotransmission, demonstrating that VGAT-dependent GABA release from interneurons is required for the development of inhibitory synapses onto excitatory neurons. Perineuronal nets were increased in the cortex of ErbB4-Vgat-/- mice.","method":"Conditional (ErbB4-Cre) Vgat knockout mice; immunohistochemistry; electrophysiology for inhibitory neurotransmission","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific conditional knockout with electrophysiological and morphological phenotype; single lab, two orthogonal methods","pmids":["29431653"],"is_preprint":false},{"year":2022,"finding":"De novo missense variants in SLC32A1 located in helices lining the putative GABA transport pathway reduce quantal size, consistent with impaired filling of synaptic vesicles with GABA. A fourth variant in the N-terminus does not affect quantal size but increases presynaptic release probability, causing more severe synaptic depression during high-frequency stimulation. Thus, SLC32A1 variants can impair GABAergic neurotransmission through at least two distinct mechanisms.","method":"Functional evaluation of patient-derived variants in murine neuronal cell culture; in silico structural modeling; quantal size measurements; high-frequency stimulation electrophysiology","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro functional assay with mutagenesis/variant analysis in neuronal model, in silico structural modeling, two mechanistically distinct variant classes identified; single lab but multiple orthogonal approaches","pmids":["36073542"],"is_preprint":false},{"year":2018,"finding":"In VGAT-Cre mice, insertion of Cre recombinase into the VGAT locus disrupts VGAT mRNA and protein expression, impairing GABAergic synaptic transmission in the hippocampus and predisposing mice to epilepsy after mild electrical kindling.","method":"Quantitative PCR; immunocytochemistry; Western blot; electrophysiology; EEG kindling model","journal":"Epilepsia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (qPCR, Western blot, electrophysiology) confirming that VGAT disruption reduces GABAergic transmission; single lab","pmids":["32954490"],"is_preprint":false},{"year":2018,"finding":"VIAAT (SLC32A1) immunoreactivity is localized to basal infoldings and basal portions of lateral plasma membranes of distal tubular epithelial cells in mouse kidney, not in vesicles or vacuoles within these cells, suggesting a non-vesicular, paracrine/autocrine function in renal GABA signaling.","method":"Immunohistochemistry (immuno-DAB and immuno-gold electron microscopy) in mouse kidney tissue","journal":"Annals of anatomy","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single localization study without functional consequence established, single lab, single method","pmids":["30448467"],"is_preprint":false},{"year":2017,"finding":"Accumulation of human tau in mouse hippocampus increases miR-92a, which targets the vGAT mRNA 3' UTR and inhibits vGAT (SLC32A1) translation, selectively suppressing vGAT protein expression among GABA-related factors and reducing extracellular GABA levels and GABAergic inhibitory postsynaptic potentials.","method":"Luciferase reporter assay for miR-92a targeting of vGAT 3' UTR; Western blot; GABA ELISA; electrophysiology (eIPSP); antagomir rescue experiments in vivo","journal":"Molecular therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct 3' UTR reporter assay plus rescue experiments with antagomir, two orthogonal methods; single lab","pmids":["28129110"],"is_preprint":false}],"current_model":"SLC32A1 (VGAT/VIAAT) is the sole vesicular transporter that loads both GABA and glycine into synaptic vesicles of inhibitory neurons; it localizes to synaptic vesicles in GABAergic and glycinergic terminals, its transport activity is driven by the vesicular proton electrochemical gradient, and the balance between glycine and GABA filling is determined by cytosolic amino acid concentrations set by co-expressed plasmalemmal transporters; disease-causing missense variants impair GABAergic neurotransmission either by reducing vesicle filling (quantal size) or by altering presynaptic release probability, and its activity is required in the CNS for circuit development, palate formation, and normal inhibitory tone."},"narrative":{"mechanistic_narrative":"SLC32A1 (VGAT/VIAAT) is the vesicular transporter that loads inhibitory neurotransmitters into synaptic vesicles of GABAergic and glycinergic nerve terminals, and it was the founding member of a distinct vesicular amino acid transporter gene family [PMID:9822734]. It mediates vesicular uptake of both GABA and glycine, with the inhibitory phenotype of a terminal set by competition between the two amino acids for transport, itself governed by cytosolic substrate concentrations established by co-expressed plasmalemmal transporters such as GlyT2 [PMID:17554001]. VGAT is essential for inhibitory transmission: its genetic loss abolishes both GABAergic and glycinergic IPSCs [PMID:25545713], whereas partial reduction selectively curtails glycinergic mini-events by shrinking the readily releasable pool of glycine vesicles [PMID:22275517]. Through VGAT-dependent inhibitory release, the transporter shapes circuit development, supporting palatogenesis via central GABAergic circuits [PMID:20333300], inhibitory synapse formation from ErbB4+/PV+ interneurons onto excitatory neurons [PMID:29431653], and normal seizure threshold [PMID:32954490]. De novo missense variants in SLC32A1 impair GABAergic neurotransmission through two distinct mechanisms: variants in helices lining the GABA transport pathway reduce vesicular quantal size, while an N-terminal variant increases presynaptic release probability [PMID:36073542]. VGAT expression is post-transcriptionally repressible, as tau-driven miR-92a targets the vGAT 3' UTR to suppress translation and reduce GABAergic inhibition [PMID:28129110].","teleology":[{"year":1998,"claim":"Established the molecular identity and subcellular home of the vesicular inhibitory transporter, defining VGAT as a synaptic-vesicle protein of GABAergic and glycinergic terminals.","evidence":"Quantitative immunogold EM with epitope-specific antibodies and triple labeling for VGAT, GABA, and glycine in rat CNS","pmids":["9822734"],"confidence":"High","gaps":["Localization alone did not demonstrate transport activity","Substrate specificity not yet resolved"]},{"year":2007,"claim":"Resolved how a single transporter handles two substrates, showing that glycine vs GABA loading is set by competition driven by cytosolic concentrations from plasmalemmal transporters.","evidence":"Reconstitution in neuroendocrine cells with GlyT1/GlyT2/GABA transporters, double-sniffer patch-clamp quantal measurements, and UNC-47 ortholog mutagenesis","pmids":["17554001"],"confidence":"High","gaps":["Did not define the structural basis of dual-substrate recognition","Coupling to the proton gradient inferred but not directly dissected here"]},{"year":2010,"claim":"Placed VGAT function in a developmental pathway, showing its CNS action drives palatogenesis rather than a local tissue role.","evidence":"Oral explant cultures, muscimol pharmacological rescue, CNS-specific conditional Gad1 knockout, and Viaat germline knockout mice","pmids":["20333300"],"confidence":"High","gaps":["Identity of the central circuits coupling inhibitory transmission to palate development unresolved","Mechanism downstream of GABA-A signaling not mapped"]},{"year":2012,"claim":"Demonstrated dose-sensitivity of VGAT, with partial loss selectively impairing glycinergic over GABAergic mini-events.","evidence":"Heterozygous VGAT knockout mice with mIPSC patch-clamp, Western blot, HPLC amino acid quantification, and pain behavior assays","pmids":["22275517"],"confidence":"High","gaps":["Why glycinergic transmission is preferentially vulnerable to reduced VGAT not fully explained","Restricted to dorsal horn neurons"]},{"year":2014,"claim":"Established VGAT as strictly required for vesicular release of both GABA and glycine and ranked its loss against GAD isoform losses in development.","evidence":"VGAT, GAD67, and GAD65/67 double knockout mice with IPSC electrophysiology and anatomical phenotyping","pmids":["25545713"],"confidence":"High","gaps":["Does not separate developmental from acute physiological requirements","Tissue-level mechanism of omphalocele/cleft palate not detailed"]},{"year":2015,"claim":"Revealed that VGAT can be co-sorted with VGLUT1 into shared vesicles, enabling activity-regulated co-release of glutamate and GABA.","evidence":"Confocal immunofluorescence co-localization and electrophysiology with sequential receptor blockers under network-activity manipulation in rat cortical neurons","pmids":["25749864"],"confidence":"Medium","gaps":["Molecular mechanism of co-sorting unknown","Functional significance for circuit output not established"]},{"year":2017,"claim":"Identified a post-transcriptional control point, showing tau-induced miR-92a represses VGAT translation to weaken inhibition.","evidence":"Luciferase 3' UTR reporter, Western blot, GABA ELISA, eIPSP electrophysiology, and in vivo antagomir rescue in mouse hippocampus","pmids":["28129110"],"confidence":"Medium","gaps":["Generalizability beyond tau pathology contexts unclear","Other regulators of VGAT translation not surveyed"]},{"year":2018,"claim":"Showed cell-type-specific VGAT requirement for inhibitory synapse development from ErbB4+/PV+ interneurons onto excitatory neurons.","evidence":"ErbB4-Cre conditional Vgat knockout mice with immunohistochemistry and inhibitory neurotransmission electrophysiology","pmids":["29431653"],"confidence":"Medium","gaps":["Link between perineuronal net increase and altered inhibition not mechanistically resolved","Single interneuron lineage examined"]},{"year":2018,"claim":"Demonstrated that disrupting the VGAT locus impairs hippocampal GABAergic transmission and predisposes to epilepsy.","evidence":"VGAT-Cre knock-in mice analyzed by qPCR, Western blot, electrophysiology, and EEG kindling","pmids":["32954490"],"confidence":"Medium","gaps":["Confound of Cre insertion as a tool line rather than a designed disease model","Threshold of VGAT reduction needed for seizure susceptibility undefined"]},{"year":2018,"claim":"Reported an unexpected non-vesicular VGAT localization at the plasma membrane of renal distal tubule cells, hinting at a paracrine GABA role outside synapses.","evidence":"Immuno-DAB and immunogold electron microscopy in mouse kidney","pmids":["30448467"],"confidence":"Low","gaps":["Single localization study without functional consequence established","No transport or signaling assay in kidney","Not independently confirmed"]},{"year":2022,"claim":"Connected SLC32A1 to human disease, defining two distinct mechanisms by which de novo variants impair GABAergic transmission.","evidence":"Functional evaluation of patient-derived variants in murine neurons, in silico structural modeling, quantal size measurement, and high-frequency stimulation electrophysiology","pmids":["36073542"],"confidence":"High","gaps":["High-resolution structure of the transport pathway absent","Mechanism by which the N-terminal variant raises release probability not detailed"]},{"year":null,"claim":"How VGAT couples the vesicular proton gradient to dual GABA/glycine transport at atomic resolution, and whether its non-synaptic localizations carry physiological function, remain open.","evidence":"No discovery in the timeline resolves the transport mechanism structurally or functionally validates extrasynaptic VGAT","pmids":[],"confidence":"Low","gaps":["No experimental structure of the transport pathway","Functional role of renal/plasma-membrane VGAT untested","Stoichiometry of proton coupling not measured"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,2,4]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[0,5]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[9]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[2,4,6,8]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,4,6]}],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9H598","full_name":"Vesicular inhibitory amino acid transporter","aliases":["GABA and glycine transporter","Solute carrier family 32 member 1","Vesicular GABA transporter","hVIAAT"],"length_aa":525,"mass_kda":57.4,"function":"Antiporter that exchanges vesicular protons for cytosolic 4-aminobutanoate or to a lesser extend glycine, thus allowing their secretion from nerve terminals. The transport is equally dependent on the chemical and electrical components of the proton gradient (By similarity). May also transport beta-alanine (By similarity). Acidification of GABAergic synaptic vesicles is a prerequisite for 4-aminobutanoate uptake (By similarity)","subcellular_location":"Cytoplasmic vesicle membrane; Presynapse","url":"https://www.uniprot.org/uniprotkb/Q9H598/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC32A1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SLC32A1","total_profiled":1310},"omim":[{"mim_id":"620774","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 114; DEE114","url":"https://www.omim.org/entry/620774"},{"mim_id":"620755","title":"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 12; GEFSP12","url":"https://www.omim.org/entry/620755"},{"mim_id":"619659","title":"SYNAPTOSOME-ASSOCIATED PROTEIN 47; SNAP47","url":"https://www.omim.org/entry/619659"},{"mim_id":"616440","title":"SOLUTE CARRIER FAMILY 32 (GABA VESICULAR TRANSPORTER), MEMBER 1; SLC32A1","url":"https://www.omim.org/entry/616440"},{"mim_id":"612406","title":"DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17","url":"https://www.omim.org/entry/612406"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Cytosol","reliability":"Uncertain"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":44.4}],"url":"https://www.proteinatlas.org/search/SLC32A1"},"hgnc":{"alias_symbol":["VGAT","bA122O1.1"],"prev_symbol":["VIAAT"]},"alphafold":{"accession":"Q9H598","domains":[{"cath_id":"1.20.1740.10","chopping":"117-413_431-523","consensus_level":"high","plddt":90.4646,"start":117,"end":523}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H598","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H598-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H598-F1-predicted_aligned_error_v6.png","plddt_mean":78.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC32A1","jax_strain_url":"https://www.jax.org/strain/search?query=SLC32A1"},"sequence":{"accession":"Q9H598","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H598.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H598/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H598"}},"corpus_meta":[{"pmid":"9822734","id":"PMC_9822734","title":"The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons.","date":"1998","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9822734","citation_count":501,"is_preprint":false},{"pmid":"19766173","id":"PMC_19766173","title":"Fluorescent labeling of both GABAergic and glycinergic neurons in vesicular GABA transporter (VGAT)-venus transgenic mouse.","date":"2009","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19766173","citation_count":110,"is_preprint":false},{"pmid":"17554001","id":"PMC_17554001","title":"The transporters GlyT2 and VIAAT cooperate to determine the vesicular glycinergic phenotype.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17554001","citation_count":73,"is_preprint":false},{"pmid":"28129110","id":"PMC_28129110","title":"Correcting miR92a-vGAT-Mediated GABAergic Dysfunctions Rescues Human Tau-Induced Anxiety in Mice.","date":"2017","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/28129110","citation_count":45,"is_preprint":false},{"pmid":"16572456","id":"PMC_16572456","title":"Vesicular glutamate (VGlut), GABA (VGAT), and acetylcholine (VACht) transporters in basal forebrain axon terminals innervating the lateral hypothalamus.","date":"2006","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16572456","citation_count":44,"is_preprint":false},{"pmid":"35887307","id":"PMC_35887307","title":"Investigating the Role of GABA in Neural Development and Disease Using Mice Lacking GAD67 or VGAT Genes.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35887307","citation_count":40,"is_preprint":false},{"pmid":"25741243","id":"PMC_25741243","title":"Gestational and early postnatal hypothyroidism alters VGluT1 and VGAT bouton distribution in the neocortex and hippocampus, and behavior in rats.","date":"2015","source":"Frontiers in neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/25741243","citation_count":37,"is_preprint":false},{"pmid":"20219572","id":"PMC_20219572","title":"Developmental localization of potassium chloride co-transporter 2 (KCC2), GABA and vesicular GABA transporter (VGAT) in the postnatal mouse somatosensory cortex.","date":"2010","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/20219572","citation_count":34,"is_preprint":false},{"pmid":"25545713","id":"PMC_25545713","title":"GAD65/GAD67 double knockout mice exhibit intermediate severity in both cleft palate and omphalocele compared with GAD67 knockout and VGAT knockout mice.","date":"2014","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25545713","citation_count":30,"is_preprint":false},{"pmid":"30155524","id":"PMC_30155524","title":"VGAT and VGLUT2 expression in MCH and orexin neurons in double transgenic reporter mice.","date":"2018","source":"IBRO reports","url":"https://pubmed.ncbi.nlm.nih.gov/30155524","citation_count":28,"is_preprint":false},{"pmid":"25104925","id":"PMC_25104925","title":"GABAergic and glycinergic inhibitory synaptic transmission in the ventral cochlear nucleus studied in VGAT channelrhodopsin-2 mice.","date":"2014","source":"Frontiers in neural circuits","url":"https://pubmed.ncbi.nlm.nih.gov/25104925","citation_count":26,"is_preprint":false},{"pmid":"29431653","id":"PMC_29431653","title":"Regulation of Synapse Development by Vgat Deletion from ErbB4-Positive Interneurons.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29431653","citation_count":25,"is_preprint":false},{"pmid":"21396926","id":"PMC_21396926","title":"Expression of VGluT1 and VGAT mRNAs in human dorsolateral prefrontal cortex during development and in schizophrenia.","date":"2011","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/21396926","citation_count":23,"is_preprint":false},{"pmid":"20333300","id":"PMC_20333300","title":"Cleft palate is caused by CNS dysfunction in Gad1 and Viaat knockout mice.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20333300","citation_count":22,"is_preprint":false},{"pmid":"25749864","id":"PMC_25749864","title":"Co-expression of VGLUT1 and VGAT sustains glutamate and GABA co-release and is regulated by activity in cortical neurons.","date":"2015","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25749864","citation_count":22,"is_preprint":false},{"pmid":"27956032","id":"PMC_27956032","title":"Alterations in hypoglossal motor neurons due to GAD67 and VGAT deficiency in mice.","date":"2016","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/27956032","citation_count":21,"is_preprint":false},{"pmid":"29671710","id":"PMC_29671710","title":"Functionally Complete Excision of Conditional Alleles in the Mouse Suprachiasmatic Nucleus by Vgat-ires-Cre.","date":"2018","source":"Journal of biological rhythms","url":"https://pubmed.ncbi.nlm.nih.gov/29671710","citation_count":21,"is_preprint":false},{"pmid":"22275517","id":"PMC_22275517","title":"Impaired glycinergic synaptic transmission and enhanced inflammatory pain in mice with reduced expression of vesicular GABA transporter (VGAT).","date":"2012","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22275517","citation_count":21,"is_preprint":false},{"pmid":"36073542","id":"PMC_36073542","title":"De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Impaired GABAergic Neurotransmission.","date":"2022","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/36073542","citation_count":20,"is_preprint":false},{"pmid":"32954490","id":"PMC_32954490","title":"Characterization of kindled VGAT-Cre mice as a new animal model of temporal lobe epilepsy.","date":"2020","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/32954490","citation_count":15,"is_preprint":false},{"pmid":"25808645","id":"PMC_25808645","title":"Electrophysiological and morphological properties of neurons in the prepositus hypoglossi nucleus that express both ChAT and VGAT in a double-transgenic rat model.","date":"2015","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25808645","citation_count":15,"is_preprint":false},{"pmid":"34038384","id":"PMC_34038384","title":"Association of SLC32A1 Missense Variants With Genetic Epilepsy With Febrile Seizures Plus.","date":"2021","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/34038384","citation_count":14,"is_preprint":false},{"pmid":"28848395","id":"PMC_28848395","title":"Few, Activity-Dependent, and Ubiquitous VGLUT1/VGAT Terminals in Rat and Mouse Brain.","date":"2017","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28848395","citation_count":14,"is_preprint":false},{"pmid":"31944441","id":"PMC_31944441","title":"VGLUT-VGAT expression delineates functionally specialised populations of vasopressin-containing neurones including a glutamatergic perforant path-projecting cell group to the hippocampus in rat and mouse brain.","date":"2020","source":"Journal of neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31944441","citation_count":13,"is_preprint":false},{"pmid":"22490609","id":"PMC_22490609","title":"Ontogenetic changes in the distribution of the vesicular GABA transporter VGAT correlate with the excitation/inhibition shift of GABA action.","date":"2012","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/22490609","citation_count":13,"is_preprint":false},{"pmid":"29063602","id":"PMC_29063602","title":"Inhibitory neuron-specific Cre-dependent red fluorescent labeling using VGAT BAC-based transgenic mouse lines with identified transgene integration sites.","date":"2017","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29063602","citation_count":12,"is_preprint":false},{"pmid":"30084046","id":"PMC_30084046","title":"Age-related loss of VGLUT1 excitatory, but not VGAT inhibitory, immunoreactive terminals on motor neurons in spinal cords of old sarcopenic male mice.","date":"2018","source":"Biogerontology","url":"https://pubmed.ncbi.nlm.nih.gov/30084046","citation_count":11,"is_preprint":false},{"pmid":"30420019","id":"PMC_30420019","title":"Repeated low level domoic acid exposure increases CA1 VGluT1 levels, but not bouton density, VGluT2 or VGAT levels in the hippocampus of adult mice.","date":"2018","source":"Harmful algae","url":"https://pubmed.ncbi.nlm.nih.gov/30420019","citation_count":7,"is_preprint":false},{"pmid":"36038028","id":"PMC_36038028","title":"Examining ventral subiculum and basolateral amygdala projections to the nucleus accumbens shell: Differential expression of VGLuT1, VGLuT2 and VGaT in the rat.","date":"2022","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/36038028","citation_count":6,"is_preprint":false},{"pmid":"34487121","id":"PMC_34487121","title":"Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy.","date":"2021","source":"Journal of visualized experiments : JoVE","url":"https://pubmed.ncbi.nlm.nih.gov/34487121","citation_count":5,"is_preprint":false},{"pmid":"15729141","id":"PMC_15729141","title":"Ethanol induces GAD67 and VGAT in slice cultures of newborn rat cerebral cortex.","date":"2005","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/15729141","citation_count":5,"is_preprint":false},{"pmid":"28918256","id":"PMC_28918256","title":"Transgene is specifically and functionally expressed in retinal inhibitory interneurons in the VGAT-ChR2-EYFP mouse.","date":"2017","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28918256","citation_count":4,"is_preprint":false},{"pmid":"35211693","id":"PMC_35211693","title":"Postpartum State, but Not Maternal Caregiving or Level of Anxiety, Increases Medial Prefrontal Cortex GAD65 and vGAT in Female Rats.","date":"2022","source":"Frontiers in global women's health","url":"https://pubmed.ncbi.nlm.nih.gov/35211693","citation_count":3,"is_preprint":false},{"pmid":"25839430","id":"PMC_25839430","title":"γHV68 vGAT: a viral pseudoenzyme pimping for PAMPs.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/25839430","citation_count":3,"is_preprint":false},{"pmid":"30448467","id":"PMC_30448467","title":"Expression and localization of VIAAT in distal uriniferous tubular epithelium of mouse.","date":"2018","source":"Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","url":"https://pubmed.ncbi.nlm.nih.gov/30448467","citation_count":2,"is_preprint":false},{"pmid":"17598093","id":"PMC_17598093","title":"Amino acid transporter (VIAAT, VGLUT2) and chloride cotransporter (KCC1, KCC2 and NKCC1) expression in the vestibular nuclei of intact and labyrinthectomized rat.","date":"2007","source":"Experimental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/17598093","citation_count":1,"is_preprint":false},{"pmid":"34311052","id":"PMC_34311052","title":"Nigrostriatal dopamine depletion promoted an increase in inhibitory markers (parvalbumin, GAD67, VGAT) and cold allodynia.","date":"2021","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/34311052","citation_count":1,"is_preprint":false},{"pmid":"42187065","id":"PMC_42187065","title":"Downregulation of SLC32A1 Mediates the PAI-1 Pathway in Alleviating Hepatic Stellate Cell Activation and Liver Fibrosis.","date":"2026","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/42187065","citation_count":0,"is_preprint":false},{"pmid":"42244183","id":"PMC_42244183","title":"Treatment of spinal injury muscle spasticity by spinal subpial AAV9-GAD65/VGAT delivery: an efficacy and safety study in rat, pig and NHP.","date":"2026","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/42244183","citation_count":0,"is_preprint":false},{"pmid":"41088451","id":"PMC_41088451","title":"Control of Aedes albopictus populations by silencing of the vesicular GABA transporter (vgat) and the vesicular monoamine transporter (vmat) genes using recombinant Chlorella shRNA.","date":"2025","source":"Parasites & vectors","url":"https://pubmed.ncbi.nlm.nih.gov/41088451","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":22395,"output_tokens":3040,"usd":0.056392,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10441,"output_tokens":3392,"usd":0.068502,"stage2_stop_reason":"end_turn"},"total_usd":0.124894,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"VGAT (SLC32A1) protein specifically associates with synaptic vesicles in GABAergic and glycinergic nerve endings, as demonstrated by post-embedding immunogold quantification in rat CNS. It is the first vesicular amino acid transporter molecularly identified and defines a novel gene family distinct from other vesicular neurotransmitter transporters.\",\n      \"method\": \"Immunogold electron microscopy with epitope-specific antibodies (N- and C-terminal); triple immunolabeling for VGAT, GABA, and glycine\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct subcellular localization by quantitative immunogold EM, replicated across multiple brain regions and cell types, founding characterization paper\",\n      \"pmids\": [\"9822734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"VIAAT (SLC32A1) mediates vesicular loading of both glycine and GABA; the vesicular inhibitory phenotype (glycinergic vs GABAergic) is determined by competition between glycine and GABA for uptake by VIAAT, modulated by cytosolic amino acid concentrations established by plasmalemmal transporters. GlyT2 is more effective than GlyT1 in supporting glycinergic vesicular release because GlyT2 cannot operate in reverse mode, maintaining higher cytosolic glycine for VIAAT loading.\",\n      \"method\": \"Reconstitution in neuroendocrine cells expressing VIAAT with GlyT1, GlyT2, or GABAergic transporters; quantal release measured by double-sniffer patch-clamp technique; point mutation of UNC-47 (C. elegans VIAAT ortholog)\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — functional reconstitution in heterologous cells with direct quantal measurements, mutagenesis of ortholog, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"17554001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Reduced VGAT expression in heterozygous VGAT knockout mice selectively impairs glycinergic (not GABAergic) miniature inhibitory postsynaptic currents in spinal cord dorsal horn neurons, reducing both frequency and amplitude of glycinergic mIPSCs and shrinking the readily releasable pool of glycine-containing vesicles, leading to enhanced inflammatory pain.\",\n      \"method\": \"Heterozygous VGAT knockout mouse model; patch-clamp recording of mIPSCs in dorsal horn neurons; Western blot; behavioral assays; HPLC for amino acid content\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined electrophysiological and behavioral phenotype, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"22275517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"VIAAT (SLC32A1) function in the CNS, not in the palate tissue itself, is required for normal palatogenesis. CNS-specific inactivation of Viaat is sufficient to cause cleft palate, and GABA-A receptor agonist muscimol rescues cleft palate in Viaat mutant embryos, indicating that vesicular inhibitory transmission acts through central GABAergic circuits to support palate development.\",\n      \"method\": \"Oral explant cultures; pharmacological rescue with muscimol; CNS-specific conditional Gad1 knockout; Viaat germline knockout mouse\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — three independent experimental approaches (explant culture, pharmacological rescue, conditional CNS-specific knockout), establishing pathway position\",\n      \"pmids\": [\"20333300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"VGAT knockout mouse cultured neurons and spinal cord show virtually no GABAergic or glycinergic inhibitory postsynaptic currents, establishing that VGAT is essential for vesicular loading and release of both GABA and glycine. Genetic epistasis with GAD67 and GAD65/67 double knockouts shows that both GABAergic (via both GAD isoforms) and glycinergic transmission contribute to palate and abdominal wall development, with VGAT loss producing the most severe phenotype.\",\n      \"method\": \"VGAT knockout, GAD67 knockout, and GAD65/GAD67 double knockout mice; electrophysiology (IPSC recording); anatomical phenotyping (cleft palate, omphalocele severity)\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis across multiple knockout models with electrophysiological and anatomical readouts, establishing necessity of VGAT for inhibitory vesicular release\",\n      \"pmids\": [\"25545713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In rat primary cortical neurons, VGLUT1 and VGAT (SLC32A1) are co-sorted into the same synaptic vesicles in a subset of axon terminals, enabling co-release of glutamate and GABA from the same terminal. These mixed synapses are regulated in an activity-dependent manner: reducing network excitation decreases VGLUT1/VGAT co-expressing terminals, while blocking inhibition increases them.\",\n      \"method\": \"Immunofluorescence confocal microscopy; electrophysiology with consecutive application of selective glutamate and GABA-A receptor blockers; pharmacological manipulation of network activity\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct electrophysiological demonstration of co-release plus imaging of co-localization; single lab, two orthogonal methods\",\n      \"pmids\": [\"25749864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Conditional deletion of Vgat from ErbB4+ interneurons reduces inhibitory axo-somatic and axo-axonic synapses from PV+/ErbB4+ interneurons onto excitatory neurons and alters inhibitory neurotransmission, demonstrating that VGAT-dependent GABA release from interneurons is required for the development of inhibitory synapses onto excitatory neurons. Perineuronal nets were increased in the cortex of ErbB4-Vgat-/- mice.\",\n      \"method\": \"Conditional (ErbB4-Cre) Vgat knockout mice; immunohistochemistry; electrophysiology for inhibitory neurotransmission\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific conditional knockout with electrophysiological and morphological phenotype; single lab, two orthogonal methods\",\n      \"pmids\": [\"29431653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"De novo missense variants in SLC32A1 located in helices lining the putative GABA transport pathway reduce quantal size, consistent with impaired filling of synaptic vesicles with GABA. A fourth variant in the N-terminus does not affect quantal size but increases presynaptic release probability, causing more severe synaptic depression during high-frequency stimulation. Thus, SLC32A1 variants can impair GABAergic neurotransmission through at least two distinct mechanisms.\",\n      \"method\": \"Functional evaluation of patient-derived variants in murine neuronal cell culture; in silico structural modeling; quantal size measurements; high-frequency stimulation electrophysiology\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro functional assay with mutagenesis/variant analysis in neuronal model, in silico structural modeling, two mechanistically distinct variant classes identified; single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"36073542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In VGAT-Cre mice, insertion of Cre recombinase into the VGAT locus disrupts VGAT mRNA and protein expression, impairing GABAergic synaptic transmission in the hippocampus and predisposing mice to epilepsy after mild electrical kindling.\",\n      \"method\": \"Quantitative PCR; immunocytochemistry; Western blot; electrophysiology; EEG kindling model\",\n      \"journal\": \"Epilepsia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (qPCR, Western blot, electrophysiology) confirming that VGAT disruption reduces GABAergic transmission; single lab\",\n      \"pmids\": [\"32954490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"VIAAT (SLC32A1) immunoreactivity is localized to basal infoldings and basal portions of lateral plasma membranes of distal tubular epithelial cells in mouse kidney, not in vesicles or vacuoles within these cells, suggesting a non-vesicular, paracrine/autocrine function in renal GABA signaling.\",\n      \"method\": \"Immunohistochemistry (immuno-DAB and immuno-gold electron microscopy) in mouse kidney tissue\",\n      \"journal\": \"Annals of anatomy\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single localization study without functional consequence established, single lab, single method\",\n      \"pmids\": [\"30448467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Accumulation of human tau in mouse hippocampus increases miR-92a, which targets the vGAT mRNA 3' UTR and inhibits vGAT (SLC32A1) translation, selectively suppressing vGAT protein expression among GABA-related factors and reducing extracellular GABA levels and GABAergic inhibitory postsynaptic potentials.\",\n      \"method\": \"Luciferase reporter assay for miR-92a targeting of vGAT 3' UTR; Western blot; GABA ELISA; electrophysiology (eIPSP); antagomir rescue experiments in vivo\",\n      \"journal\": \"Molecular therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct 3' UTR reporter assay plus rescue experiments with antagomir, two orthogonal methods; single lab\",\n      \"pmids\": [\"28129110\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC32A1 (VGAT/VIAAT) is the sole vesicular transporter that loads both GABA and glycine into synaptic vesicles of inhibitory neurons; it localizes to synaptic vesicles in GABAergic and glycinergic terminals, its transport activity is driven by the vesicular proton electrochemical gradient, and the balance between glycine and GABA filling is determined by cytosolic amino acid concentrations set by co-expressed plasmalemmal transporters; disease-causing missense variants impair GABAergic neurotransmission either by reducing vesicle filling (quantal size) or by altering presynaptic release probability, and its activity is required in the CNS for circuit development, palate formation, and normal inhibitory tone.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SLC32A1 (VGAT/VIAAT) is the vesicular transporter that loads inhibitory neurotransmitters into synaptic vesicles of GABAergic and glycinergic nerve terminals, and it was the founding member of a distinct vesicular amino acid transporter gene family [#0]. It mediates vesicular uptake of both GABA and glycine, with the inhibitory phenotype of a terminal set by competition between the two amino acids for transport, itself governed by cytosolic substrate concentrations established by co-expressed plasmalemmal transporters such as GlyT2 [#1]. VGAT is essential for inhibitory transmission: its genetic loss abolishes both GABAergic and glycinergic IPSCs [#4], whereas partial reduction selectively curtails glycinergic mini-events by shrinking the readily releasable pool of glycine vesicles [#2]. Through VGAT-dependent inhibitory release, the transporter shapes circuit development, supporting palatogenesis via central GABAergic circuits [#3], inhibitory synapse formation from ErbB4+/PV+ interneurons onto excitatory neurons [#6], and normal seizure threshold [#8]. De novo missense variants in SLC32A1 impair GABAergic neurotransmission through two distinct mechanisms: variants in helices lining the GABA transport pathway reduce vesicular quantal size, while an N-terminal variant increases presynaptic release probability [#7]. VGAT expression is post-transcriptionally repressible, as tau-driven miR-92a targets the vGAT 3' UTR to suppress translation and reduce GABAergic inhibition [#10].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established the molecular identity and subcellular home of the vesicular inhibitory transporter, defining VGAT as a synaptic-vesicle protein of GABAergic and glycinergic terminals.\",\n      \"evidence\": \"Quantitative immunogold EM with epitope-specific antibodies and triple labeling for VGAT, GABA, and glycine in rat CNS\",\n      \"pmids\": [\"9822734\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Localization alone did not demonstrate transport activity\", \"Substrate specificity not yet resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved how a single transporter handles two substrates, showing that glycine vs GABA loading is set by competition driven by cytosolic concentrations from plasmalemmal transporters.\",\n      \"evidence\": \"Reconstitution in neuroendocrine cells with GlyT1/GlyT2/GABA transporters, double-sniffer patch-clamp quantal measurements, and UNC-47 ortholog mutagenesis\",\n      \"pmids\": [\"17554001\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the structural basis of dual-substrate recognition\", \"Coupling to the proton gradient inferred but not directly dissected here\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Placed VGAT function in a developmental pathway, showing its CNS action drives palatogenesis rather than a local tissue role.\",\n      \"evidence\": \"Oral explant cultures, muscimol pharmacological rescue, CNS-specific conditional Gad1 knockout, and Viaat germline knockout mice\",\n      \"pmids\": [\"20333300\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the central circuits coupling inhibitory transmission to palate development unresolved\", \"Mechanism downstream of GABA-A signaling not mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrated dose-sensitivity of VGAT, with partial loss selectively impairing glycinergic over GABAergic mini-events.\",\n      \"evidence\": \"Heterozygous VGAT knockout mice with mIPSC patch-clamp, Western blot, HPLC amino acid quantification, and pain behavior assays\",\n      \"pmids\": [\"22275517\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why glycinergic transmission is preferentially vulnerable to reduced VGAT not fully explained\", \"Restricted to dorsal horn neurons\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established VGAT as strictly required for vesicular release of both GABA and glycine and ranked its loss against GAD isoform losses in development.\",\n      \"evidence\": \"VGAT, GAD67, and GAD65/67 double knockout mice with IPSC electrophysiology and anatomical phenotyping\",\n      \"pmids\": [\"25545713\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not separate developmental from acute physiological requirements\", \"Tissue-level mechanism of omphalocele/cleft palate not detailed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Revealed that VGAT can be co-sorted with VGLUT1 into shared vesicles, enabling activity-regulated co-release of glutamate and GABA.\",\n      \"evidence\": \"Confocal immunofluorescence co-localization and electrophysiology with sequential receptor blockers under network-activity manipulation in rat cortical neurons\",\n      \"pmids\": [\"25749864\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of co-sorting unknown\", \"Functional significance for circuit output not established\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified a post-transcriptional control point, showing tau-induced miR-92a represses VGAT translation to weaken inhibition.\",\n      \"evidence\": \"Luciferase 3' UTR reporter, Western blot, GABA ELISA, eIPSP electrophysiology, and in vivo antagomir rescue in mouse hippocampus\",\n      \"pmids\": [\"28129110\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generalizability beyond tau pathology contexts unclear\", \"Other regulators of VGAT translation not surveyed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed cell-type-specific VGAT requirement for inhibitory synapse development from ErbB4+/PV+ interneurons onto excitatory neurons.\",\n      \"evidence\": \"ErbB4-Cre conditional Vgat knockout mice with immunohistochemistry and inhibitory neurotransmission electrophysiology\",\n      \"pmids\": [\"29431653\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Link between perineuronal net increase and altered inhibition not mechanistically resolved\", \"Single interneuron lineage examined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated that disrupting the VGAT locus impairs hippocampal GABAergic transmission and predisposes to epilepsy.\",\n      \"evidence\": \"VGAT-Cre knock-in mice analyzed by qPCR, Western blot, electrophysiology, and EEG kindling\",\n      \"pmids\": [\"32954490\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Confound of Cre insertion as a tool line rather than a designed disease model\", \"Threshold of VGAT reduction needed for seizure susceptibility undefined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Reported an unexpected non-vesicular VGAT localization at the plasma membrane of renal distal tubule cells, hinting at a paracrine GABA role outside synapses.\",\n      \"evidence\": \"Immuno-DAB and immunogold electron microscopy in mouse kidney\",\n      \"pmids\": [\"30448467\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single localization study without functional consequence established\", \"No transport or signaling assay in kidney\", \"Not independently confirmed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Connected SLC32A1 to human disease, defining two distinct mechanisms by which de novo variants impair GABAergic transmission.\",\n      \"evidence\": \"Functional evaluation of patient-derived variants in murine neurons, in silico structural modeling, quantal size measurement, and high-frequency stimulation electrophysiology\",\n      \"pmids\": [\"36073542\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution structure of the transport pathway absent\", \"Mechanism by which the N-terminal variant raises release probability not detailed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How VGAT couples the vesicular proton gradient to dual GABA/glycine transport at atomic resolution, and whether its non-synaptic localizations carry physiological function, remain open.\",\n      \"evidence\": \"No discovery in the timeline resolves the transport mechanism structurally or functionally validates extrasynaptic VGAT\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No experimental structure of the transport pathway\", \"Functional role of renal/plasma-membrane VGAT untested\", \"Stoichiometry of proton coupling not measured\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 2, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [2, 4, 6, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 4, 6]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}